Skip to main content

Table 6 Baseline serum SP-D levels and patients’ outcome, AKI stage and RRT of AKI patients

From: Surfactant protein-D (SP-D) gene polymorphisms and serum level as predictors of susceptibility and prognosis of acute kidney injury in the Chinese population

AKI patients Outcome AKI stage RRT
Dead Alive Stage 1 Stage 2 Stage 3 With Without
Median(25th – 75th IQR) serum SP-D(ng/ml) 149.6 (143.8–159.2) 139.5* (124.1–154.6) 124.3 (120.4–123.4) 137.7* (131.3–144.0) 156.1##(148.9–165.1) 142.7 (139.5–159.8) 140.3* (121.7–155.8)
P value 0.026 1 0.02 0.001 0.012
  1. For the serum SP-D levels and different outcome analysis
  2. *Compared with AKI patients who died, significant difference was observed. P less than 0.05
  3. For the serum SP-D levels and different AKI stage analysis
  4. *Compared with AKI stage 1,significant difference was observed. P less than 0.05
  5. ##Compared with AKI stage 3,significant difference was observed. P less than 0.01
  6. For the serum SP-D levels and RRT need
  7. *Compared with AKI patients with RRT, significant difference was observed. P less than 0.05
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us